11.000
+6,80%
2026-10-12
Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +0.7% | +0.1% | 2 / 3 | +7.0% | -0.70 pp | -0.32 pp | +7.4% | 0.00 | 8.08 | 90,2 | +7,0% | 4,7 | +0,7% | 8.08 | 8.34 | −3,1% |
| Pts | 0 | 0 | 8 | 0 | 4 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 11.000 (close price on 2026-10-12)EPS (TTM): 1.361
Financial charts
1.Revenue & growth
VND bn90,2Q2/26
1.Revenue & growth
VND bn90,2Q2/26
2.Profit & growth
VND bn4,71Q2/26
3.Profit mix (Penman)
VND bn15,9Q2/26
4.Margins & cost structure
%14.1%Q2/26
5.Returns & cash cycle
% · days7.4%Q2/26
6.Earnings quality & cash
VND bn42,2Q2/26
7.Asset structure
VND bn244Q2/26
8.Funding & debt health
VND bn · times244Q2/26
9.Revenue backlog
VND bn38,0Q2/26
10.Valuation
times · %8,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %496Q2/26
Adjusted EPS growth, latest quarter
0.7%
Average adjusted EPS growth, 3 quarters
0.1%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26